Welcome!!!
We are very proud to bring you this portal for information on cervical cancer, human papillomavirus (HPV) and the CCCaST Study. For information on HPV and Pap smears, please follow the appropriate links on your left.
About the CCCaST Study
We are conducting a clinical trial to compare the efficacy of two cervical cancer screening tests, the Pap cytology and the HPV test.
A total of 12,000 women in the Montreal metropolitan area and in St. John's, Newfoundland are currently being enrolled in the study. Eligible women are those of ages 30 to 69 years who present for their routine cervical cancer screening in selected medical settings. They must not be presently under follow-up for treatment of cervical disease.
This is a collaborative effort of researchers and physicians at McGill University, University of Montreal, the Newfoundland Public Health Laboratory, affiliated hospitals and more than 30 private clinics. Funding has been provided by the Canadian Institutes for Health Research.
The CCCaST study has completed recruitment of patients and is now in active follow-up phase. The design of the study and its preliminary findings were recently published in the medical literature.
We hope you find the information you need in this site. However, if you can't find it here, a list of related links will take you to other related websites.
We welcome your comments or questions. If you would like to learn more about the information in this site or collaborating with us in this study do not hesitate to contact us.
